| CES1 substrate |
| Filgotinib |
| Filgotinib (USAN/INN) |
| Filgotinib hydrochloride (USAN) |
| Filgotinib maleate (JAN/USAN) <JP> |
| Omidenepag |
| Omidenepag (USAN/INN) |
| Omidenepag isopropyl (JAN) <JP/US> |
| CES2 substrate |
| Filgotinib |
| Filgotinib (USAN/INN) |
| Filgotinib hydrochloride (USAN) |
| Filgotinib maleate (JAN/USAN) <JP> |
| Deucravacitinib (JAN/USAN) <JP/US> |
| Candesartan cilexetil (JP18/USP) <JP/US> |
| Irinotecan |
| Irinotecan (INN) |
| Irinotecan hydrochloride (USP); Irinotecan hydrochloride hydrate (JP18) <JP/US> |
| Irinotecan sucrosofate (USAN) |
| Rufinamide (JAN/USP/INN) <JP/US> |
| Rilmazafone |
| Rilmazafone (INN) |
| Rilmazafone hydrochloride hydrate (JP18) <JP> |
